Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-05-22
DOI
10.3389/fimmu.2019.01078
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrins in wound healing, fibrosis and tumor stroma: High potential targets for therapeutics and drug delivery
- (2018) Jonas Schnittert et al. ADVANCED DRUG DELIVERY REVIEWS
- Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Modulation of human Th17 cell responses through complement receptor 3 (CD11 b/CD18) ligation on monocyte-derived dendritic cells
- (2018) Johannes Nowatzky et al. JOURNAL OF AUTOIMMUNITY
- Filamin A Is Required for Optimal T Cell Integrin-Mediated Force Transmission, Flow Adhesion, and T Cell Trafficking
- (2018) Terhi Savinko et al. JOURNAL OF IMMUNOLOGY
- Tumor-Resident Dendritic Cells and Macrophages Modulate the Accumulation of TCR-Engineered T Cells in Melanoma
- (2018) Alastair Hotblack et al. MOLECULAR THERAPY
- Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific
- (2018) Paula Michea et al. NATURE IMMUNOLOGY
- Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors
- (2018) Paris Kosti et al. Frontiers in Immunology
- LFA-1 in T Cell Migration and Differentiation
- (2018) Brandon L. Walling et al. Frontiers in Immunology
- Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
- (2018) Aurélie Durgeau et al. Frontiers in Immunology
- A homing system targets therapeutic T cells to brain cancer
- (2018) Heba Samaha et al. NATURE
- The Tumor Vascular Endothelium as Decision Maker in Cancer Therapy
- (2018) Diana Klein Frontiers in Oncology
- Direct Rap1/Talin1 interaction regulates platelet and neutrophil integrin activity in mice
- (2018) Thomas Bromberger et al. BLOOD
- Integrin activation by talin, kindlin and mechanical forces
- (2018) Zhiqi Sun et al. NATURE CELL BIOLOGY
- Signal transduction via integrin adhesion complexes
- (2018) Jonathan D Humphries et al. CURRENT OPINION IN CELL BIOLOGY
- TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy
- (2017) William C. Dougall et al. IMMUNOLOGICAL REVIEWS
- A novel intracellular pool of LFA-1 is critical for asymmetric CD8+T cell activation and differentiation
- (2017) Tara Capece et al. JOURNAL OF CELL BIOLOGY
- Kindlin supports platelet integrin αIIbβ3 activation by interacting with paxillin
- (2017) Juan Gao et al. JOURNAL OF CELL SCIENCE
- Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses
- (2017) Byron H. Kwan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Integrin extension enables ultrasensitive regulation by cytoskeletal force
- (2017) Jing Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer
- (2017) Jung-Eun Jang et al. Cell Reports
- The Interaction of Selectins and PSGL-1 as a Key Component in Thrombus Formation and Cancer Progression
- (2017) János Kappelmayer et al. Biomed Research International
- PI3Kγ Activates Integrin α 4 and Promotes Immune Suppressive Myeloid Cell Polarization during Tumor Progression
- (2017) Philippe Foubert et al. Cancer Immunology Research
- β2 Integrins As Regulators of Dendritic Cell, Monocyte, and Macrophage Function
- (2017) Leonie Schittenhelm et al. Frontiers in Immunology
- Multiple myeloma
- (2017) Shaji K. Kumar et al. Nature Reviews Disease Primers
- Role of LFA-1 and ICAM-1 in Cancer
- (2017) Manuel Reina et al. Cancers
- Integrins as Therapeutic Targets: Successes and Cancers
- (2017) Sabine Raab-Westphal et al. Cancers
- A multicenter phase II study of volociximab in patients with relapsed metastatic melanoma
- (2017) J. Barton JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of E7820 in combination with cetuximab in subjects (pts) with metastatic and refractory colorectal cancer (CRC).
- (2017) M. B. Sawyer et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I dose-escalation study of IMGN388 in patients with solid tumors.
- (2017) D. S. Thompson et al. JOURNAL OF CLINICAL ONCOLOGY
- LFA-1 integrin antibodies inhibit leukocyte 4 1-mediated adhesion by intracellular signaling
- (2016) M. Gronholm et al. BLOOD
- Critical Role for CD103 + /CD141 + Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
- (2016) Edward W. Roberts et al. CANCER CELL
- Regulatory T cells in cancer immunotherapy
- (2016) Atsushi Tanaka et al. CELL RESEARCH
- Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies
- (2016) Camille Guillerey et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Differential Effect on Bone Lesions of Targeting Integrins: Randomized Phase II Trial of Abituzumab in Patients with Metastatic Castration-Resistant Prostate Cancer
- (2016) M. Hussain et al. CLINICAL CANCER RESEARCH
- The Integrin LFA-1 Controls T Follicular Helper Cell Generation and Maintenance
- (2016) Alexandre P. Meli et al. IMMUNITY
- Expansion and Activation of CD103 + Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
- (2016) Hélène Salmon et al. IMMUNITY
- A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of α2 integrin inhibitor E7820 in patients with advanced solid tumors
- (2016) B. Milojkovic Kerklaan et al. INVESTIGATIONAL NEW DRUGS
- A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignancies
- (2016) Geert A. Cirkel et al. INVESTIGATIONAL NEW DRUGS
- Kindlin-2 directly binds actin and regulates integrin outside-in signaling
- (2016) Kamila Bledzka et al. JOURNAL OF CELL BIOLOGY
- The integrin adhesome network at a glance
- (2016) Edward R. Horton et al. JOURNAL OF CELL SCIENCE
- Early Tumor-Infiltrating Dendritic Cells Change their Characteristics Drastically in Association with Murine Melanoma Progression
- (2016) Takeshi Nakahara et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial
- (2016) Mustafa Khasraw et al. JOURNAL OF NEURO-ONCOLOGY
- The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
- (2016) Vinit Kumar et al. TRENDS IN IMMUNOLOGY
- Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
- (2016) Vincenzo Bronte et al. Nature Communications
- Microenvironment drug resistance in multiple myeloma: emerging new players
- (2016) Lucia Di Marzo et al. Oncotarget
- Kindlin-2 cooperates with talin to activate integrins and induces cell spreading by directly binding paxillin
- (2016) Marina Theodosiou et al. eLife
- The Role of Myeloid-Derived Suppressor Cells in Patients with Solid Tumors: A Meta-Analysis
- (2016) Shuo Zhang et al. PLoS One
- Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)
- (2015) J. Vansteenkiste et al. ANNALS OF ONCOLOGY
- Rap1 and its effector RIAM are required for lymphocyte trafficking
- (2015) W. Su et al. BLOOD
- Loss of the Rap1 effector RIAM results in leukocyte adhesion deficiency due to impaired 2 integrin function in mice
- (2015) S. Klapproth et al. BLOOD
- The dendritic cell cytoskeleton promotes T cell adhesion and activation by constraining ICAM-1 mobility
- (2015) William A. Comrie et al. JOURNAL OF CELL BIOLOGY
- Optimal T Cell Activation and B Cell Antibody Responses In Vivo Require the Interaction between Leukocyte Function–Associated Antigen-1 and Kindlin-3
- (2015) Vicky Louise Morrison et al. JOURNAL OF IMMUNOLOGY
- Functional Beta2-Integrins Restrict Skin Inflammation In Vivo
- (2015) Terhi S. Savinko et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Multiple myeloma
- (2015) Christoph Röllig et al. LANCET
- Structural mechanism of integrin inactivation by filamin
- (2015) Jianmin Liu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma
- (2015) Elizabeth R. Gerstner et al. NEURO-ONCOLOGY
- Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study
- (2015) L. Burt Nabors et al. NEURO-ONCOLOGY
- Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression
- (2015) G. Wang et al. Cancer Discovery
- Structural mechanism of integrin inactivation by filamin
- (2015) Jianmin Liu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment
- (2015) Qian-Qian Zhang et al. Scientific Reports
- Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
- (2015) Bin Shang et al. Scientific Reports
- Fine-tuning Tumor Immunity with Integrin Trans-regulation
- (2015) J. M. Cantor et al. Cancer Immunology Research
- Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells
- (2015) Annie A Wu et al. OncoImmunology
- Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients withKRASwild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial
- (2014) E. Élez et al. ANNALS OF ONCOLOGY
- Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)
- (2014) J. B. Vermorken et al. ANNALS OF ONCOLOGY
- Integrin Cytoplasmic Tail Interactions
- (2014) Elizabeth M. Morse et al. BIOCHEMISTRY
- Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations
- (2014) J. C. Riches et al. BLOOD
- CD18 (ITGB2) expression in chronic lymphocytic leukaemia is regulated by DNA methylation-dependent and -independent mechanisms
- (2014) Evelyn Hutterer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
- (2014) Miranda L. Broz et al. CANCER CELL
- A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors
- (2014) Hope E. Uronis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Nectin family of cell-adhesion molecules: structural and molecular aspects of function and specificity
- (2014) Dibyendu Samanta et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape
- (2014) Deepak Mittal et al. CURRENT OPINION IN IMMUNOLOGY
- Vascular cell adhesion molecule-1 (VCAM-1)-An increasing insight into its role in tumorigenicity and metastasis
- (2014) Martin Schlesinger et al. INTERNATIONAL JOURNAL OF CANCER
- Differences in binding to the ILK complex determines kindlin isoform adhesion localization and integrin activation
- (2014) C. Huet-Calderwood et al. JOURNAL OF CELL SCIENCE
- Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
- (2014) Roger Stupp et al. LANCET ONCOLOGY
- The integrin adhesome: from genes and proteins to human disease
- (2014) Sabina E. Winograd-Katz et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- MUC1: a multifaceted oncoprotein with a key role in cancer progression
- (2014) Sritama Nath et al. TRENDS IN MOLECULAR MEDICINE
- Loss of beta2-integrin-mediated cytoskeletal linkage reprogrammes dendritic cells to a mature migratory phenotype
- (2014) Vicky Louise Morrison et al. Nature Communications
- T-Cell and NK-Cell Infiltration into Solid Tumors: A Key Limiting Factor for Efficacious Cancer Immunotherapy
- (2014) I. Melero et al. Cancer Discovery
- Reprogramming Tumor-Infiltrating Dendritic Cells for CD103+CD8+ Mucosal T-cell Differentiation and Breast Cancer Rejection
- (2014) T.-C. Wu et al. Cancer Immunology Research
- Metabolic Regulation of T Lymphocytes
- (2013) Nancie J. MacIver et al. Annual Review of Immunology
- The 2 integrin-kindlin-3 interaction is essential for T-cell homing but dispensable for T-cell activation in vivo
- (2013) V. L. Morrison et al. BLOOD
- Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer
- (2013) Y Ino et al. BRITISH JOURNAL OF CANCER
- Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A-Specific T Cells
- (2013) B. Weide et al. CLINICAL CANCER RESEARCH
- The Mechanism of Kindlin-Mediated Activation of Integrin αIIbβ3
- (2013) Feng Ye et al. CURRENT BIOLOGY
- A Multicenter Phase 1 Study of EMD 525797 (DI17E6), a Novel Humanized Monoclonal Antibody Targeting αv Integrins, in Progressive Castration-resistant Prostate Cancer with Bone Metastases After Chemotherapy
- (2013) Manfred Wirth et al. EUROPEAN UROLOGY
- Genetically modified T cells targeting neovasculature efficiently destroy tumor blood vessels, shrink established solid tumors and increase nanoparticle delivery
- (2013) Xinping Fu et al. INTERNATIONAL JOURNAL OF CANCER
- Intercellular adhesion molecule-1 (ICAM-1) expression correlates with oral cancer progression and induces macrophage/cancer cell adhesion
- (2013) Yu Usami et al. INTERNATIONAL JOURNAL OF CANCER
- Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
- (2013) Aurélien Marabelle et al. JOURNAL OF CLINICAL INVESTIGATION
- Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer
- (2013) J. Yu et al. JOURNAL OF IMMUNOLOGY
- Vascular E-Selectin Expression Correlates with CD8 Lymphocyte Infiltration and Improved Outcome in Merkel Cell Carcinoma
- (2013) Olga K. Afanasiev et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Design, Synthesis, and Functional Evaluation of Leukocyte Function Associated Antigen-1 Antagonists in Early and Late Stages of Cancer Development
- (2013) Eider San Sebastián et al. JOURNAL OF MEDICINAL CHEMISTRY
- Role of tumor-infiltrating CD11b+ antigen-presenting cells in the progression of gastric cancer
- (2013) Yoshihiro Okita et al. JOURNAL OF SURGICAL RESEARCH
- The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: Insight into disease biology and new targeted therapies
- (2013) Jan A. Burger et al. SEMINARS IN CANCER BIOLOGY
- Getting Leukocytes to the Site of Inflammation
- (2013) W. A. Muller VETERINARY PATHOLOGY
- v Integrins in Angiogenesis and Cancer
- (2013) S. M. Weis et al. Cold Spring Harbor Perspectives in Medicine
- Ways to Enhance Lymphocyte Trafficking into Tumors and Fitness of Tumor Infiltrating Lymphocytes
- (2013) Matteo Bellone et al. Frontiers in Oncology
- Clinical Perspectives on Targeting of Myeloid Derived Suppressor Cells in the Treatment of Cancer
- (2013) Yana G. Najjar et al. Frontiers in Oncology
- A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human αν integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer
- (2012) A. Heidenreich et al. ANNALS OF ONCOLOGY
- Phase Ib safety and pharmacokinetic study of volociximab, an anti-α5β1 integrin antibody, in combination with carboplatin and paclitaxel in advanced non-small-cell lung cancer
- (2012) B. Besse et al. ANNALS OF ONCOLOGY
- The leucocyte β2 (CD18) integrins: the structure, functional regulation and signalling properties
- (2012) Suet‑Mien Tan BIOSCIENCE REPORTS
- Distinct roles for talin-1 and kindlin-3 in LFA-1 extension and affinity regulation
- (2012) C. T. Lefort et al. BLOOD
- Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study
- (2012) Petra dos Santos et al. Diagnostic Pathology
- Human Tissues Contain CD141hi Cross-Presenting Dendritic Cells with Functional Homology to Mouse CD103+ Nonlymphoid Dendritic Cells
- (2012) Muzlifah Haniffa et al. IMMUNITY
- Lung cancer cell invasion and expression of intercellular adhesion molecule-1 (ICAM-1) are attenuated by secretory phospholipase A2 inhibition
- (2012) Jessica A. Yu et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma
- (2012) Kevin B. Kim et al. MELANOMA RESEARCH
- A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma
- (2011) S O'Day et al. BRITISH JOURNAL OF CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Phase I Study of E7820, an Oral Inhibitor of Integrin -2 Expression with Antiangiogenic Properties, in Patients with Advanced Malignancies
- (2011) M. Mita et al. CLINICAL CANCER RESEARCH
- Effector T-Cell Infiltration Positively Impacts Survival of Glioblastoma Patients and Is Impaired by Tumor-Derived TGF-
- (2011) J. Lohr et al. CLINICAL CANCER RESEARCH
- Efalizumab
- (2011) Marina Talamonti et al. Expert Opinion On Drug Safety
- A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer
- (2011) Katherine M. Bell-McGuinn et al. GYNECOLOGIC ONCOLOGY
- CD103 is a hallmark of tumor-infiltrating regulatory T cells
- (2011) David Anz et al. INTERNATIONAL JOURNAL OF CANCER
- Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer
- (2011) Evgeniy Eruslanov et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic value of intercellular adhesion molecule (ICAM)-1 expression in breast cancer
- (2011) Christine Schröder et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells
- (2011) Daniel T. Fisher et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
- (2011) Paul F. Robbins et al. JOURNAL OF CLINICAL ONCOLOGY
- Contact-Dependent T Cell Activation and T Cell Stopping Require Talin1
- (2011) S. A. Wernimont et al. JOURNAL OF IMMUNOLOGY
- Absence of 2 Integrins Impairs Regulatory T Cells and Exacerbates CD4+ T Cell-Dependent Autoimmune Carditis
- (2011) S. Haasken et al. JOURNAL OF IMMUNOLOGY
- Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery
- (2011) Mark R. Gilbert et al. JOURNAL OF NEURO-ONCOLOGY
- Transendothelial migration of lymphocytes mediated by intraendothelial vesicle stores rather than by extracellular chemokine depots
- (2011) Ziv Shulman et al. NATURE IMMUNOLOGY
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Rolling Cell Adhesion
- (2010) Rodger P. McEver et al. Annual Review of Cell and Developmental Biology
- Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
- (2010) J. N. Kochenderfer et al. BLOOD
- LFA-1 activity state on dendritic cells regulates contact duration with T cells and promotes T-cell priming
- (2010) S. Balkow et al. BLOOD
- A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin αvβ3, ± dacarbazine in patients with stage IV metastatic melanoma
- (2010) Peter Hersey et al. CANCER
- Selective Depletion of Foxp3+ Regulatory T Cells Improves Effective Therapeutic Vaccination against Established Melanoma
- (2010) K. Klages et al. CANCER RESEARCH
- Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
- (2010) R. K. Shrimali et al. CANCER RESEARCH
- Conditional Regulatory T-Cell Depletion Releases Adaptive Immunity Preventing Carcinogenesis and Suppressing Established Tumor Growth
- (2010) M. W. L. Teng et al. CANCER RESEARCH
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Oxidized Low-density Lipoprotein-induced Proinflammatory Cytokine Response in Macrophages are Suppressed by CD4+CD25+Foxp3+ Regulatory T Cells Through Downregulating Toll Like Receptor 2-mediated Activation of NF-ĸB
- (2010) Ming Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Molecular profiling to identify relevant immune resistance mechanisms in the tumor microenvironment
- (2010) Thomas F Gajewski et al. CURRENT OPINION IN IMMUNOLOGY
- Indirect Inhibition of Toll-like Receptor and Type I Interferon Responses by ITAM-Coupled Receptors and Integrins
- (2010) Lu Wang et al. IMMUNITY
- Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium
- (2010) Deborah A. Bradley et al. INVESTIGATIONAL NEW DRUGS
- A phase I study of continuous infusion cilengitide in patients with solid tumors
- (2010) Peter H. O’Donnell et al. INVESTIGATIONAL NEW DRUGS
- Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma
- (2010) Roger Stupp et al. JOURNAL OF CLINICAL ONCOLOGY
- Human CD141+(BDCA-3)+dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
- (2010) Sarah L. Jongbloed et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+cells as homologues of mouse CD8+dendritic cells
- (2010) Annabell Bachem et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tumor masses support naive T cell infiltration, activation, and differentiation into effectors
- (2010) Elizabeth D. Thompson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- An LFA-1 ( L 2) Small-Molecule Antagonist Reduces Inflammation and Joint Destruction in Murine Models of Arthritis
- (2010) S. J. Suchard et al. JOURNAL OF IMMUNOLOGY
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
- (2010) Maria R Parkhurst et al. MOLECULAR THERAPY
- Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b
- (2010) Chaofeng Han et al. NATURE IMMUNOLOGY
- Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment
- (2010) G.-O. Ahn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Assessing Long-Term Drug Safety: Lessons (Re) Learned from Raptiva
- (2010) Nicole M. Seminara et al. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
- Efalizumab
- (2009) James E Frampton et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Regulation of integrin activity and signalling
- (2009) Carl G. Gahmberg et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Loss of Kindlin-3 in LAD-III eliminates LFA-1 but not VLA-4 adhesiveness developed under shear flow conditions
- (2009) E. Manevich-Mendelson et al. BLOOD
- Comparative Analysis of Normal versus CLL B-Lymphocytes Reveals Patient-Specific Variability in Signaling Mechanisms Controlling LFA-1 Activation by Chemokines
- (2009) A. Montresor et al. CANCER RESEARCH
- Circulating B-Cell Chronic Lymphocytic Leukemia Cells Display Impaired Migration to Lymph Nodes and Bone Marrow
- (2009) T. N. Hartmann et al. CANCER RESEARCH
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
- (2009) H. Harlin et al. CANCER RESEARCH
- Genetic etiologies of leukocyte adhesion defects
- (2009) Amos Etzioni CURRENT OPINION IN IMMUNOLOGY
- The promise and potential pitfalls of chimeric antigen receptors
- (2009) Michel Sadelain et al. CURRENT OPINION IN IMMUNOLOGY
- Biomolecular Network Reconstruction Identifies T-Cell Homing Factors Associated With Survival in Colorectal Cancer
- (2009) Bernhard Mlecnik et al. GASTROENTEROLOGY
- LFA-1 Affinity Regulation Is Necessary for the Activation and Proliferation of Naive T Cells
- (2009) Yang Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inflamed Lymphatic Endothelium Suppresses Dendritic Cell Maturation and Function via Mac-1/ICAM-1-Dependent Mechanism
- (2009) S. Podgrabinska et al. JOURNAL OF IMMUNOLOGY
- LFA-1 is critical for regulatory T cell homeostasis and function
- (2009) Jillian Wohler et al. MOLECULAR IMMUNOLOGY
- Kindlin-3 is required for β2 integrin–mediated leukocyte adhesion to endothelial cells
- (2009) Markus Moser et al. NATURE MEDICINE
- An integrin αvβ3–c-Src oncogenic unit promotes anchorage-independence and tumor progression
- (2009) Jay S Desgrosellier et al. NATURE MEDICINE
- Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis
- (2009) Andrea T. Borchers et al. Seminars in Immunopathology
- Soluble Intercellular Adhesion Molecule-1 as a Prognostic Marker for Stage II Colorectal Cancer Patients
- (2008) Yuji Toiyama et al. ANNALS OF SURGICAL ONCOLOGY
- CD18-dependent activation of the neutrophil NADPH oxidase during phagocytosis of Escherichia coli or Staphylococcus aureus is regulated by class III but not class I or II PI3Ks
- (2008) K. E. Anderson et al. BLOOD
- CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential
- (2008) Tait D. Shanafelt et al. BRITISH JOURNAL OF HAEMATOLOGY
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
- (2008) C. Marcela Diaz-Montero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cell Motility in Chronic Lymphocytic Leukemia: Defective Rap1 and L 2 Activation by Chemokine
- (2008) K. J. Till et al. CANCER RESEARCH
- Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via 5-Integrin, which Is a Therapeutic Target
- (2008) K. Sawada et al. CANCER RESEARCH
- The Mammary Progenitor Marker CD61/ 3 Integrin Identifies Cancer Stem Cells in Mouse Models of Mammary Tumorigenesis
- (2008) F. Vaillant et al. CANCER RESEARCH
- Regulatory T Cells and Immune Tolerance
- (2008) Shimon Sakaguchi et al. CELL
- Volociximab, a Chimeric Monoclonal Antibody that Specifically Binds 5 1 Integrin: A Phase I, Pharmacokinetic, and Biological Correlative Study
- (2008) A. D. Ricart et al. CLINICAL CANCER RESEARCH
- CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia
- (2008) D. Rossi et al. HAEMATOLOGICA
- Integrin-dependent phagocytosis - spreading from microadhesion to new concepts
- (2008) A. G. Dupuy et al. JOURNAL OF CELL SCIENCE
- TGF-β–dependent suppressive function of Tregs requires wild-type levels of CD18 in a mouse model of psoriasis
- (2008) Honglin Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase I Clinical Trial of Cilengitide in Children With Refractory Brain Tumors: Pediatric Brain Tumor Consortium Study PBTC-012
- (2008) Tobey J. MacDonald et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme
- (2008) David A. Reardon et al. JOURNAL OF CLINICAL ONCOLOGY
- Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells
- (2008) Rachael A. Clark et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Serum Level of Intercellular Adhesion Molecule-1 in Children with Malignant Lymphoma
- (2008) Nabil Abdelrazik et al. MEDICAL PRINCIPLES AND PRACTICE
- Kindlin-3 is essential for integrin activation and platelet aggregation
- (2008) Markus Moser et al. NATURE MEDICINE
- Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
- (2008) E. A. Murphy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cholestatic liver damage is mediated by lymphocyte function antigen-1–dependent recruitment of leukocytes
- (2008) Stefan Dold et al. SURGERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started